Kyle Saitta (laboratory of Dr. Cheryl Dreyfus, School of Medicine) was selected to give his PhD dissertation research as a podium presentation during the 2019 Mid-Atlantic Pharmacology Society meeting at Temple University. The title of Kyle’s presentation was “The Selective Group I Metabotropic Glutamate Receptor Agonist 2-Chloro-5-hydroxyphenylglycine (CHPG) Enhances BDNF and Reverses Demyelination”. Congratulations on this outstanding honor Kyle!